4//SEC Filing
Fraser Claire 4
Accession 0000950170-24-042655
CIK 0001609809other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:45 PM ET
Size
5.3 KB
Accession
0000950170-24-042655
Insider Transaction Report
Form 4
Fraser-Liggett Claire
Director
Transactions
- Award
Stock Option (right to buy
2024-04-04+60,000→ 60,000 totalExercise: $0.76Exp: 2034-04-03→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001382031
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:45 PM ET
- Size
- 5.3 KB